1 Supplemental Information Methods Mice A conditional targeting vector for the DNase II gene was designed to delete exons 3 to 5, as shown in Supplementary Figure S1. In brief, a neo-loxP cassette carrying the PGK promoter-driven neo gene flanked by lox sequences (provided by Dr. J. Takeda) was inserted into a Hind III site in intron 5 of the DNase II gene. A 0.44 kb Sma I fragment containing exons 1 and 2 was replaced with a DNA fragment carrying the corresponding sequences and a loxP sequence. The diphtheria toxin A-fragment (DT-A) driven by the tk promoter was inserted at the 3’ end of the vector. To establish mice carrying the floxed allele of the DNase II gene, the linearized targeting vector was introduced into R1 ES cells by electroporation. ES clones resistant to G418 (150 g/ml) were screened for homologous recombination by PCR. Positive clones were aggregated with BDF1 morula embryos to generate DNase II3lox/+ mice. To remove the Neo cassette, DNase II3lox/+ mice were crossed with E2a-Cre transgenic mice, and the resultant DNase IIflox/+E2a-CreT (mosaic) mice were crossed with DNase II+/- mice to establish DNase IIflox/+ and DNase IIflox/- mice. The Mx1-Cre transgene was then introduced into the DNase IIflox/+ or DNase IIflox/- mice. DNase IIflox/-Mx1-CreT mice at the age of 4-6 weeks were injected i.p. with 1.5 g/weight (g) of poly(I:C)(Sigma) 3 times at 1-day interval to activate the IFN gene. Most of the mice were housed in a specific pathogen-free facility at Osaka University Medical School and Oriental Bioservices. Some conditional knock-out mice were kept in a 2 conventional facility at Osaka University Medical School. DNase II-/-IFN-IR-/- mice had the C57BL6 background. The conditional DNase II targeting mice carried a mixed background of the 129 and C57BL6 strains. All animal experiments were carried out in accordance with protocols approved by the Osaka University Medical School Animal Care and Use Committee. Primers used for genotyping The following primers were used to genotype the respective wild-type and mutant alleles. DNase II: wild-type sense, 5’-GCCCATCTAGACTAACTTTC-3’ mutant sense, 5’-GATTCGCAGCGCATCGCCTT-3’ common antisense, 5’-GAGTCTTAGTCCTTTGCTCCG-3’ IFN-IR: wild-type antisense, 5’-AAGATGTGCTGTTCCCTTCCTCTGCTCTGA-3’ mutant antisense, 5’-CCTGCGTGCAATCCATCTTG-3’ common sense, 5’-ATTATTAAAAGAAAAGACGAGGCGAAGTGG-3’ TLR-9: wild-type antisense, 5’-GAGTCTTAGTCCTTTGCTCCG-3’ mutant antisense, 5’-ATCGCCTTCTATCGCCTTCTTGACGAG-3’ common sense, 5’-GCAATGGAAAGGACTGTCCACTTTGTG-3’ Mx1-Cre: sense, 5’-GTGGGCACAGCAAGCTCAGG-3’ antisense, 5’-TCCATGAGTGAACGAACCT-3’ flox allele: sense, 5’-CGCACGTCTAAGAAACCATT-3’ antisense, 5’-CAGTACTAGTGAACCTCTTC-3’ Treatment with anti-TNF mAb 3 A rat hybridoma MP6-XT22 producing a neutralizing anti-TNF mAb was obtained from Dr. K. Okumura. The hybridomas were cultured in GIT medium (Nihon Seiyaku), and the mAb was purified by fractionation with (NH4)2SO3. The mAb (20 g/g body weight) was administered twice a week by i.p. injection, and clinical parameters were assessed three days after the last injection. MRI and radiography For MRI, the mice were anesthetized by i.p. injection of pentobarbital sodium (Dainippon Pharmaceutical). 1H-MRI was performed at 3.0 T using a Signa Horizon LX 3T (General Electric), and MR images were obtained using T1, T2, and fat-suppressed T2-weighted sequences with a coil designed for small animals. Pixel sizes were 0.12 x 0.12 x 1.50 mm3 (1.50-mm thickness). Radiography of limbs was performed using the MX-20 Specimen Radiography system (Faxitron X-ray), and imaged on high-speed radiographic film (Fuji Photo Film). Histology To prepare paraffin sections, tissues were fixed with 4% paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.2) containing 4% sucrose, and embedded in paraffin. Joints were incubated at room temperature for 24 h in Morse’s solution (10% sodium citrate and 22.5% formic acid) for decalcification before paraffinization. The blocks were sectioned at 4 m, deparaffinized, and subjected to staining with hematoxylin and eosin, or DAPI (Dojindo). For frozen sections, the paraformaldehyde-fixed tissues were placed in PBS containing 20% sucrose, embedded in OCT compound (SAKURA), quickly frozen, 4 sectioned at 6 m, and mounted onto MAS-coated glass slides (Matsunami). The joints were decalcified by incubation at 4°C for 11 days in 10% EDTA (pH 7.4) after fixation. TRAP staining was performed using an Acid Phosphatase Leukocyte kit (Sigma Diagnostics). For immunohistochemical staining, the sections were post-fixed with cold acetone and treated for 10 min with Peroxidase Blocking Reagent (Dako). After blocking non-specific binding sites with 5% goat serum and 1% BSA in PBS, the sections were stained with biotinylated mAb. The sections were further incubated with streptavidin-conjugated horseradish peroxidase (HRP) (Roche) with 3,3’-diaminobenzidine tetrachloride (DAB) (DAB Kit, Zymed) as the substrate, and counterstained with Mayer’s hematoxylin (WAKO). The mAbs used were anti-CD68 (FA-11; Serotec), and anti-CD4 (H129.19; Beckton Dickinson). For the histochemical staining of TNF, sections were post-fixed in cold acetone, and washed with HEPES-buffered saline containing 0.1% saponin (HBSS). After blocking the non-specific binding sites with 5% rabbit serum and 1% BSA in HBSS, the sections were incubated at 4°C overnight with goat anti-TNF (L-19; Santa Cruz). The signals were detected with biotin-labelled rabbit anti-goat IgG (Vector), followed by incubation with Cy3-labelled streptavidin (Sigma). The sections were mounted with Fluorsave containing 0.5 g/ml DAPI, and observed by fluorescence microscopy (Olympus). Real-time PCR Limbs were removed from just above the ankle joint and homogenized with a polytron homogenizer. Total RNA was prepared using an ISOGEN kit (Nippon Gene), treated with RNase-free DNase I (Qiagen), and purified using an RNeasy kit (Qiagen). RNA (2 g) was 5 reverse-transcribed in a total volume of 20 l using Superscript III (Invitrogen) with oligo(dT) as primer, and Real-Time PCR was carried out using a LightCycler (Roche Diagnostics). The amount of specific mRNA was quantified at the point where the LightCycler System detected the upstroke of the exponential phase of PCR accumulation, referred to the standard curve, and was normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or -actin mRNA in each individual sample. Primers for Real-time PCR The primers used for Real-Time PCR were as follows: TNF- sense primer, 5’-CACAGAAAGCATGATCCGCGACGT-3’ antisense primer, 5’-CGGCAGAGAGGAGGTTGACTTTCT-3’ IFN-, sense primer, 5’-CCACCACAGCCCTCTCCATCAACTAT-3’ antisense primer, 5’-CAAGTGGAGAGCAGTTGAGGACATC-3’ IFN-, sense primer, 5’-CTTTGCAGCTCTTCCTCATGGCTGTTTCTG-3’ antisense primer, 5’-TGACGCTTATGTTGTTGCTGATGGCCTG-3’ TGF- sense primer, 5’-GACCGCAACAACGCCATCTA-3’ antisense primer, 5’-GGCGTATCAGTGGGGGTCAG-3’ IL-1, sense primer, 5’-CCAGCTTCAAATCTCACAGCAG-3’ antisense, 5’-CTTCTTTGGGTATTGCTTGGGATC-3’ IL-6, sense primer, 5’-ACAACGATGATGCACTTGCAGA-3’ antisense primer, 5’-GATGAATTGGATGGTCTTGGTC-3’ IL-10, sense primer, 5’- TGGCCCAGAAATCAAGGAGC -3’ antisense primer, 5’-CAGCAGACTCAATACACACT-3’ 6 IL-18, sense primer, 5’-ACTGTACAACCGCAGTAATACGG-3’ antisense primer, 5’-AGTGAACATTACAGATTTATCCC-3’ DNase II, sense primer, 5’-GAGACGGTGATCAAGAACCAA-3’ antisense primer, 5’-AATTTTGCCAGAACTGGACCT-3’ MMP-3, sense primer, 5’-ACTCTACCACTCAGCCAAGG-3’ antisense primer, 5’-TCCAGAGAGTTAGACTTGGTGG-3’ -actin, sense primer 5’-TGTGATGGTGGGAATGGGTCAG-3’ antisense primer 5’-TTTGATGTCACGCACGATTTCC-3’ GAPDH, sense primer 5’-AACGACCCCTTCATTGAC-3’ antisense primer 5’-TCCACGACATACTCAGCAC-3’ Analysis of DNA in serum To quantify the DNA in serum, sera were diluted 4-fold with lysis buffer (100 mM Tris-HCl buffer [pH 8.5] containing 5 mM EDTA, 0.2% SDS, 200 mM NaCl, and 100 g/ml Proteinase K), and incubated at 55°C for 4 h. The DNA concentration was then determined using a PicoGreen kit (Molecular Probes) and a SPECTRAmax GEMINI XS (Molecular Devices) with an excitation wavelength of 480 nm and emission wavelength of 520 nm. Each sample was treated with DNase I, and the value obtained after DNase Itreatment was subtracted as background.